Deutsche Bank AG acquired a new stake in Kimberly-Clark Corporation (NASDAQ:KMB - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,567,356 shares of the company's stock, valued at approximately $172,049,000. Deutsche Bank AG owned 0.47% of Kimberly-Clark as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently modified their holdings of the company. Perigon Wealth Management LLC acquired a new position in Kimberly-Clark in the 2nd quarter worth approximately $506,000. Commerzbank Aktiengesellschaft FI acquired a new stake in Kimberly-Clark during the 2nd quarter valued at approximately $4,362,000. Pursue Wealth Partners LLC purchased a new stake in shares of Kimberly-Clark in the 2nd quarter valued at $238,000. Trust Co. of Vermont purchased a new stake in shares of Kimberly-Clark in the 2nd quarter valued at $1,259,000. Finally, Principle Wealth Partners LLC acquired a new stake in shares of Kimberly-Clark in the second quarter worth $6,182,000. Institutional investors and hedge funds own 76.29% of the company's stock.
Analyst Ratings Changes
A number of research analysts recently issued reports on KMB shares. Weiss Ratings upgraded shares of Kimberly-Clark from a "hold (c-)" rating to a "hold (c)" rating in a research report on Tuesday, July 28th. Seaport Research Partners raised Kimberly-Clark to a "buy" rating in a research report on Tuesday, August 4th. Barclays lifted their price objective on Kimberly-Clark from $101.00 to $115.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 21st. TD Cowen upped their target price on Kimberly-Clark from $96.00 to $104.00 and gave the stock a "hold" rating in a research note on Wednesday, August 5th. Finally, Piper Sandler raised their target price on Kimberly-Clark from $115.00 to $121.00 and gave the stock an "overweight" rating in a report on Wednesday, June 17th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, Kimberly-Clark has an average rating of "Hold" and an average price target of $117.93.
Read Our Latest Stock Analysis on Kimberly-Clark
Kimberly-Clark Stock Performance
Shares of NASDAQ KMB opened at $107.72 on Wednesday. The company's fifty day moving average price is $108.45 and its 200 day moving average price is $103.25. Kimberly-Clark Corporation has a 1 year low of $92.42 and a 1 year high of $136.17. The company has a market capitalization of $35.83 billion, a PE ratio of 18.32, a price-to-earnings-growth ratio of 5.25 and a beta of 0.26. The company has a debt-to-equity ratio of 3.45, a quick ratio of 0.69 and a current ratio of 0.91.
Kimberly-Clark (NASDAQ:KMB - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $1.80 EPS for the quarter, missing the consensus estimate of $2.01 by ($0.21). Kimberly-Clark had a net margin of 11.79% and a return on equity of 143.92%. The firm had revenue of $4.19 billion for the quarter, compared to analyst estimates of $4.22 billion. During the same quarter in the prior year, the business posted $1.92 EPS. The firm's quarterly revenue was up .6% compared to the same quarter last year. On average, research analysts predict that Kimberly-Clark Corporation will post 7.43 earnings per share for the current year.
Kimberly-Clark Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 2nd. Stockholders of record on Friday, September 4th will be given a dividend of $1.28 per share. The ex-dividend date is Friday, September 4th. This represents a $5.12 dividend on an annualized basis and a dividend yield of 4.8%. Kimberly-Clark's dividend payout ratio (DPR) is 87.07%.
About Kimberly-Clark
(
Free Report)
Kimberly-Clark Corporation is a U.S.-based multinational manufacturer of personal care and consumer tissue products. The company develops, produces and markets a range of consumer brands and professional products, including facial and bathroom tissues, disposable diapers and training pants, feminine care, incontinence products and workplace hygiene solutions. Known for consumer-facing names such as Kleenex, Huggies, Kotex, Cottonelle and Scott, as well as professional offerings under Kimberly-Clark Professional and KleenGuard, the company supplies goods to retail, healthcare and institutional customers.
Founded in 1872 in Neenah, Wisconsin, Kimberly-Clark has expanded from its 19th-century paper-making roots into a global household and workplace products company.
Featured Articles
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Corporation (NASDAQ:KMB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.